Too many medicine residues end up in surface water. RIVM has investigated the impact on surface water resulting from five painkillers that are also available without a prescription.

In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.

The Dutch government wants to reduce the percentage of people who smoke, are overweight or whose alcohol consumption is problematic. To this end, the National Prevention Agreement was drawn up in 2018, with ambitions for 2040. The 2040 ambitions for all three theme’s will not be achieved.

Recent measurements commissioned by the provinces of Zeeland, Noord-Holland and Zuid-Holland have revealed the presence of PFAS in sea foam along the Dutch coast, as reported by RIVM. It is as yet unclear what the presence of PFAS in sea foam means for human health.

Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.

The Dutch public health and healthcare will face three crucial challenges in the period to 2050. This is according to RIVM’s preview of the Dutch Public Health Foresight Study 2024.

Pure fruit juice is less bad for your health than drinks with added sugar, such as soft drinks. At the same time, it is not suitable as a direct substitute for eating fruit. This is Floor Scheffers' conclusion in her doctoral thesis.

Young people aged 12–25 feel that the COVID-19 pandemic made them miss out on a key stage of their lives. They have indicated that important milestones, such as graduation ceremonies or the start of student life, passed them by. This is evident from the latest quarterly study conducted by the Network for Health Research in Disasters.

A new RIVM study has shown that the COVID-19 pandemic intensified existing socio-economic differences. People on lower incomes visited test lanes less often during the pandemic, but were admitted to hospital and intensive care with COVID-19 more often.

Each year, approximately 27,000 people are diagnosed with Lyme disease. For most, the symptoms disappear after treatment with antibiotics. Unfortunately, 25% of those treated have chronic symptoms, such as fatigue, concentration disorders or pain.